Reply to 'Vericiguat in heart failure with reduced ejection fraction: the right choice above all else? The answer may lie in time'

Eur J Heart Fail. 2023 Aug;25(8):1470-1471. doi: 10.1002/ejhf.2964. Epub 2023 Jul 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Heart Failure* / drug therapy
  • Heterocyclic Compounds, 2-Ring*
  • Humans
  • Pyrimidines

Substances

  • vericiguat
  • Heterocyclic Compounds, 2-Ring
  • Pyrimidines